Ági Erickson, MS, is the director of Community Health Center Inc. in Middletown, Connecticut. She has experience implementing and managing high-profile health care programs and initiatives with an emphasis on establishing long-term growth and sustainability.
Erickson is an advocate for using innovation and technology to increase output and improve efficiency. She has years of experience in health care and management, with a history of recognition.
Aleka Delafield Heinrici, MD, is a board-certified family physician who received her medical degree from Oregon Health and Science University and completed a residency at University of California, San Francisco, in family and community medicine.
Heinrici’s approach is based on treating the whole person with multiple modalities, conventional and complementary. She practices a broad range of medicine, including primary and preventative medicine, women’s health and options counseling, and addiction and recovery medicine. She has years of experience in the fields of detoxification and addiction medicine. The opioid epidemic pulled to her serve the community in this area. This includes her work to promote all approaches to addiction, including education and prevention, improving access to care, and promoting harm/risk reduction.
Heinrici is currently the addiction specialist for a large Federally Qualified Health Center. She also provides medical directorship to local residential treatment centers.
Brian Hurley, MD, MBA, DFASAM, is an addiction physician and the medical director for substance use-related care integration at the Los Angeles County Health Agency. He is board-certified in addiction medicine and addiction psychiatry.
Hurley completed a fellowship program in addiction psychiatry at New York University School of Medicine and residency training at the Massachusetts General Hospital and McLean Hospital, where he was the chief resident in addiction psychiatry. He has served in various roles for the American Society of Addiction Medicine, the American Medical Association (AMA), the Massachusetts Society of Addiction Medicine, the New York Society of Addiction Medicine, and the California Society of Addiction Medicine.
Additionally, he is a former national president and director of student programming for the American Medical Student Association, through which he has been an invited speaker at medical schools throughout the world, addressing topics ranging from global health equity, health care reform, pharmaceutical advertising and ethics, LGBT equality, and medical student wellness. He served on the American Medical Colleges’ Lesbian, Gay, Bisexual, Transgender and Differences of Sexual Development Patient Care Advisory Committee’s Ad-Hoc Committee on the Learning Environment. Hurley is also a past chair of the AMA’s Gay Lesbian Bisexual and Transgender Advisory Committee.
The CFCB consultancy team has more than 20 years of experience in behavioral health care, and has worked with acute care hospitals, primary care clinics, group practices, and behavioral health care programs to plan and implement a variety of patient safety and quality improvement strategies.
It offers consultative services to executive leadership and managers within organizations for quality improvement, health and safety, credentialing, accreditation, and regulatory compliance.
CFCB aims to effectively matrix consultants and experts committed to ensuring that all health plans and health systems launch organization-wide opioid initiatives with the goal of driving down opioid-related morbidity and mortality in California.
The California Primary Care Association’s (CPCA’s) mission is to lead and position community health centers and networks as key players in the health care delivery system to improve the health status of their communities.
In addition to offering a comprehensive statewide training and technical assistance program, CPCA also actively works on policy issues that impact community health centers and the patients they serve. For these reasons, the association is positioned to provide both policy and programmatic training and technical assistance to community health centers on many topics, including integrating medication-assisted treatment into primary care.
David Liu, MD, JD, PhD, began his practice in addition medicine during his time as the director of a Federally Qualified Health Center on the island of Moloka’i, Hawaii, where he worked in an integrated practice with psychologists to diagnose and treat behavioral health issues, including substance use disorder.
After moving to California, he continued to work toward institutionalizing evidence-based and best practices in treatment for substance use disorder, including medication-assisted treatment. In his current role, he has contributed to the development of a complete behavioral health clinic, including mental health and substance use disorders, in a managed care system.
Joe Anthony Sepulveda, MD, is a specialist in addiction medicine. He leads the MAT program at Family Health Centers of San Diego, an award-winning Federally Qualified Health Center.
Sepulveda holds board certifications from both the American Board of Psychiatry and Neurology and the American Board of Prevention Medicine. He holds a buprenorphine prescribing waiver, and has since 2010.
He has extensive experience treating opioid-dependent patients as well as providing technical assistance, training, and coaching to fellow providers in addition to medical staff, administrators, students, and lay people. He has also provided MAT and hub-and-spoke consulting services to the largest Federally Qualified Health Center in the US.
John Bachman, PhD, has had a long career in psychology and behavioral health. He currently provides behavioral health services at the El Dorado Community Health Center, a Federally Qualified Health Center.
Bachman is a licensed psychologist and has served in senior and executive roles at Stanford Hospital, El Dorado County Mental Health Department, United Behavioral Health Care, and in his own private practice in Palo Alto, California. He has worked with inpatient and outpatient programs, and has provided consulting services on topics including quality, staff retention, and performance improvement.
Currently, his work at El Dorado Community Health Center has been integral in developing the center’s complex care clinic and its medication-assisted treatment program for opioid-dependent patients.
JSI is a public health consulting and research organization that seeks to improve health in the US and around the world. Since its founding in 1978, it has implemented projects in 106 countries, and currently operates eight US and more than 40 international offices, with a workforce of 500 US-based professionals providing research, assessment, evaluation, practice improvement, and other consultation services.
JSI has evaluated primary care and behavioral health integration across 67 sites in Maine, assessed the integration of care between medical, substance use, and mental health providers in Vermont, and worked with a collaborative in Humboldt County, California, to facilitate the development and design of an Accountable Community for Health focused on alcohol and other drug misuse. It has worked specifically on MAT projects in New Hampshire, Massachusetts, Colorado, and Maine.
Kenneth Saffier, MD, is a family physician with Contra Costa Regional Medical Center’s family medicine residency program and specializes in addiction medicine and chronic pain management. He is medical director of the interdisciplinary opioid use disorders treatment program, Choosing Change.
Saffier has practiced medicine for many years. He was director of the Addiction Education Champions Project of the Medical Education and Research Foundation for the Treatment of Addiction, designed to integrate addiction medicine into residency curricula. He is also a board member of the foundation.
He has been a member of the Motivational Interviewing Network of Trainers since 2012. He has provided over 50 motivational interviewing training sessions, including workshops at national conferences, and has also provided training for multiple health systems, hospitals, health centers, and residency training programs. He teaches topics in addiction medicine and has partnered in the presentation of multiple educational workshops.
Saffier is also an active mentor in the Providers Clinical Support System for Medication-Assisted Therapies and for five years has conducted Substance Abuse and Mental Health Services Administration-approved buprenorphine waiver training sessions on local and regional levels and at national conferences of the Society of Teachers of Family Medicine.
Lisa Netherland, MD, is a physician at Lifelong Medical Care in Berkeley, California. She has been providing medication-assisted therapy for opiates for nearly four years, and had a long history of work in addiction medicine prior to becoming a physician.
During her residency, she did several electives at various types of buprenorphine clinics, including the Office-Based Buprenorphine Induction Clinic at the University of California, San Francisco, a private practice addiction clinic in Sacramento, and a community-based clinic also in Sacramento.
At Lifelong, Netherland works together with a case manager and recovery support counselor to provide the full scope of assessment, induction, stabilization, and maintenance to patients. She provided support to physicians as Lifelong expanded MAT services to its other clinics. She provides mentorship, consults, and facilitates the clinical case conferences at monthly MAT meetings.
As medical director of the Center for Key Populations, Marwan Haddad, MD, MPH, leads the medication-assisted treatment program for substance use disorder at Community Health Center (CHC), Inc.
Hadded has been prescribing buprenorphine for opioid use disorders since 2007, and led the growth of CHC’s MAT programs to all 12 sites across the agency. Since January 2012, Haddad has led CHC’s Project ECHO HIV, hepatitis C, and buprenorphine programs, reaching numerous clinics and providers in multiple states across the nation.
He has taught and lectured at state and national conferences on HIV, hepatitis C, buprenorphine, and integrated care. He has published research on the integration of buprenorphine in community health centers examining substance use and primary care outcomes.
Medscape is a medical education company that accounts for a large share of all online continuing medical education (CME) programs. Medscape Education has also been a resource for the US government in training health care providers on pain management and appropriate opioid prescribing.
The firm has developed online training in the form of CME activities that have reached 387,000 learners for programs sponsored by the Substance Abuse and Mental Health Services Administration, the National Institute on Drug Abuse, and the National Center for Complementary and Integrative Health, the complementary medicine institute at the National Institutes of Health.
To develop CME, Medscape will hire faculty subject matter experts, develop manuscripts, arrange filming in the case of multimedia courses, accredit the activity using its in-house accreditation staff, host and promote the activity on its site, and provide CME activity participation metrics to health plans.
Owen Murphy, LMFT, is an addiction specialist and licensed therapist working full-time as part of a behavioral/nursing hub-and-spoke team. For the past five years, he has developed and delivered the behavioral and case management addiction program components of four primary and specialist outpatient MAT programs for opioid use disorder.
Murray has conducted training in group therapy and for the state of New Hampshire, in addition to assisting physicians in prescribing buprenorphine and extended-release naltrexone. He is participating in the development of a regional integrated treatment network, and helping transition patients according to American Society of Addiction Medicine criteria between different levels of care. He also spent decades as a language instructor in Japan, New Zealand, Qatar, and Indonesia.
Murray would like to offer his expertise to other clinicians and health systems looking to integrate MAT into their practice.
Ralph E. Retherford, MD, has decades of experience in emergency and family medicine, drug and alcohol rehabilitation, and opioid safety. He is a Medi-Cal buprenorphine prescriber, and is comfortable in using the drug for both detox and maintenance.
Scott H. Silverman is a crisis coach, behavioral health advisor, and leads the team at Confidential Recovery, an intensive substance abuse recovery program for adults.
Silverman has received numerous awards recognizing his leadership and dedication to the improvement of his community. He has deep knowledge and experience with the relationship between substance abuse, unemployment, poverty, homelessness, and incarceration. He is a frequent speaker to political, business, and community groups on the need for justice system reform to prevent homelessness, enhance public safety, and reduce costs for California’s taxpayers by helping former inmates to avoid recidivism and re-incarceration.
Tipu Khan, MD, is a core faculty member at Ventura County Medical Center Family Medicine Residency and is an assistant clinical professor at the University of California, Los Angeles.
At Ventura County Medical Center, he has built and leads the addiction medicine curriculum, and leads the DATA 2000 waiver training for residents and community physicians. He is a board-certified addiction sub-specialist and has an interest in the management of substance use disorders during pregnancy.
The Substance Use Warmline (SUW) of the Clinician Consultation Center (CCC) (based in the Department of Family and Community Medicine at the University of California San Francisco–Zuckerberg San Francisco General Hospital) offers free telephone consultations for clinicians and prescribers.
The SUW is a free clinician-to-clinician telephone consultation service that provides education and directly supports clinicians in implementing opioid safety and addiction treatment. The SUW multidisciplinary team of dedicated substance use, HIV, and hepatitis experts and educators includes addiction medicine-certified physicians, clinical pharmacists, and advanced practice nurses.
Key components of SUW consultations include developing individualized strategies to identify patients at risk, advising on safer opioid and benzodiazepine prescribing, facilitating realistic medication changes, implementing overdose prevention strategies, connecting patients with opioid and substance treatment programs, implementing MAT, and discussing complex comorbidities and social supports with the goal of developing alternative treatment plans for patients. SUW consultations are both case-specific consultations and general discussions. All consultations are confidential for both the prescriber and patient per HIPAA standards.
A unique strength of the SUW is that SUW consultants provide colleague-to-colleague individualized case consultation as needed by the treating clinician. The process is non-judgmental and goal-directed. The SUW is available Monday through Friday, 8:00AM–5:00PM PT.